Instagram and YouTube owners built ‘addiction machines’, trial hears

Los Angeles, CA – A landmark jury trial began today in Los Angeles, thrusting the parent companies of Instagram and YouTube into the national spotlight as plaintiffs argue the tech giants intentionally engineered “addiction machines” designed to maximize user engagement at the cost of public mental health.

The civil action, targeting Meta (owner of Instagram) and Alphabet (owner of YouTube), scrutinizes their platform design and algorithmic practices. Attorneys for the plaintiffs delivered powerful opening statements, characterizing the sophisticated social media mechanisms as deliberately manipulative tools built for endless scrolling and perpetual engagement. They alleged that internal documents would show the companies were long aware of the potential psychological harm their products posed, particularly to young users, yet prioritized profit metrics above safety.

The core of the case rests on claims of negligence and defective product design. The plaintiffs contend that the use of variable rewards, highly personalized content feeds, and aggressive notification strategies constitute a design flaw intended solely to capture and retain user attention, ultimately leading to addictive behaviors and mental distress. This trial differs significantly from previous litigation that focused on content moderation failures; instead, it targets the foundational mechanics of how these digital products function.

Legal observers suggest the outcome of the lawsuit could set a precedent for how technology products are regulated worldwide. Proving causation between platform design and specific mental health injuries, however, remains a significant legal challenge for the plaintiffs’ counsel.

Defense attorneys are expected to counter the allegations by focusing on platform safety features, user control, and the platforms’ status as protected forums for free expression. They are anticipated to argue that the companies have invested heavily in tools designed to promote digital wellbeing and that user agency dictates time spent on the applications. The trial is scheduled to feature testimony from former company insiders, data scientists, and medical experts over the coming weeks.